Aptose Biosciences (TSE:APS) Stock Price Crosses Below 200 Day Moving Average – Should You Sell?

Aptose Biosciences Inc. (TSE:APS) (NASDAQ:APTO) shares crossed below its two hundred day moving average during trading on Wednesday . The stock has a two hundred day moving average of C$10.66 and traded as low as C$4.98. Aptose Biosciences shares last traded at C$4.98, with a volume of 1,087 shares.

Analyst Ratings Changes

Separately, Alliance Global Partners upgraded Aptose Biosciences to a “strong-buy” rating in a research report on Thursday, February 27th.

Aptose Biosciences Stock Performance

The company has a current ratio of 1.05, a quick ratio of 5.41 and a debt-to-equity ratio of -117.37. The company’s 50-day moving average price is C$6.77 and its two-hundred day moving average price is C$10.66. The company has a market cap of C$214.43 million, a P/E ratio of -0.99 and a beta of 1.36.

Aptose Biosciences Company Profile

Aptose Biosciences Inc, a clinical-stage biotechnology company, discovers and develops personalized therapies addressing unmet medical needs in oncology in Canada. Its lead clinical program is APTO-253, which is a Phase I clinical trial for the treatment of patients with relapsed or refractory hematologic malignancies.